Methotrexat Sandoz

Methotrexate, the active ingredient in Methotrexat Sandoz, is an antimetabolite (folate antagonist) presented as a parenteral preparation for intraarterial, intramuscular and intravenous use. It is employed to treat certain cancers, autoimmune disorders and trophoblastic conditions in adult and pediatric patients.

GNH USA supplies Methotrexat Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, oncology centres and pharmacies worldwide.

Methotrexat Sandoz is used in diseases where folate metabolism is a therapeutic target, primarily in oncology and autoimmune disorders. - Rheumatoid arthritis: reduces joint inflammation and slows disease progression. - Psoriasis: limits skin cell proliferation and improves lesions. - Acute lymphoblastic leukemia: interferes with leukemic cell replication. - Osteosarcoma: inhibits tumor growth in bone tissue. - Gestational trophoblastic disease: promotes resolution of abnormal trophoblastic tissue.

Methotrexat Sandoz may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Nausea and vomiting. - Fatigue or malaise. - Oral mucosal ulceration. - Mild elevation of liver enzymes. - Transient rash or itching. - Mild decrease in blood cell counts.

Serious or Rare Side Effects: - Severe bone marrow suppression leading to pancytopenia. - Pulmonary fibrosis or interstitial pneumonitis. - Clinically significant hepatotoxicity or cirrhosis. - Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Acute renal failure. - Life‑threatening infections due to immunosuppression.

When prescribing Methotrexat Sandoz, clinicians should observe several safety measures. - Pregnancy: contraindicated (Category X) – avoid use in pregnant women. - Renal function: assess before initiation and monitor regularly. - Liver function: obtain baseline tests and conduct periodic monitoring. - Hematologic status: monitor complete blood counts throughout therapy. - Drug interactions: review concomitant medications for known interactions. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Methotrexat Sandoz can alter the activity of several other medicines.

Major Interactions (Avoid): - Non‑steroidal anti‑inflammatory drugs (NSAIDs): increase methotrexate toxicity. - Penicillins: reduce methotrexate efficacy. - Live vaccines: heightened risk of severe infection. - Estrogen‑containing hormones: may raise toxicity risk. - High‑dose folic acid: can diminish therapeutic effect.

Moderate Interactions (Monitor Closely): - Sulfonamides: may enhance myelosuppression. - Proton pump inhibitors: affect renal clearance of methotrexate. - Azathioprine: additive bone‑marrow suppression. - Trimethoprim: increased risk of toxicity. - Alcohol: may exacerbate liver injury.